The FT reports Pfizer ( PFE +1.28%) has matched Novo Nordisk 's ( NVO +0.48%) bid for Metsera ( MTSR 2.46%) for up to $10 ...
Stock futures were little changed Thursday, a day after major indexes rebounded from a selloff in tech stocks caused by ...
Novo Nordisk’s oral therapy Wegovy (semaglutide) reduced cardiovascular risk factors in the Phase III OASIS 4 trial. Being ...
(Reuters) -Shares of obesity drugmakers Eli Lilly and Novo Nordisk rose early on Thursday in anticipation of a White House ...
The highest dose of Eli Lilly's weekly injection helped patients with obesity or who are overweight lose 20.1% of their body ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback